Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and hydrodissection for carpal tunnel syndrome
NCT02986828Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous platelet-rich plasma in carpal tunnel syndrome (CTS) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Visual Analog Scale for Pain at 1 year. Started Dec 2016; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT02986828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986828.